| 000 | 01147 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517195739.0 | ||
| 264 | 0 | _c20181212 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1748-6963 | ||
| 024 | 7 |
_a10.2217/nnm-2017-0378 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFisusi, Funmilola A | |
| 245 | 0 | 0 |
_aNanomedicines in the treatment of brain tumors. _h[electronic resource] |
| 260 |
_bNanomedicine (London, England) _c03 2018 |
||
| 300 |
_a579-583 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBrain Neoplasms _xpathology |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xtrends |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNanomedicine _xtrends |
| 650 | 0 | 4 |
_aNanoparticles _xtherapeutic use |
| 650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
| 650 | 0 | 4 |
_aTheranostic Nanomedicine _xtrends |
| 700 | 1 | _aSchätzlein, Andreas G | |
| 700 | 1 | _aUchegbu, Ijeoma F | |
| 773 | 0 |
_tNanomedicine (London, England) _gvol. 13 _gno. 6 _gp. 579-583 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/nnm-2017-0378 _zAvailable from publisher's website |
| 999 |
_c28020473 _d28020473 |
||